Anterior pituitary function in Rathke’s cleft cysts versus nonfunctioning pituitary adenomas

Author(s):  
Fujii M ◽  
Nakagawa A ◽  
Tachibana O ◽  
Iizuka H ◽  
Koya D
Neurosurgery ◽  
2003 ◽  
Vol 53 (5) ◽  
pp. 1086-1094 ◽  
Author(s):  
Bruce E. Pollock ◽  
Paul C. Carpenter

Abstract OBJECTIVE To evaluate tumor control rates and complications after stereotactic radiosurgery for patients with nonfunctioning pituitary adenomas. METHODS Between 1992 and 2000, 33 patients underwent radiosurgery for treatment of nonfunctioning pituitary adenomas. Thirty-two patients (97%) had undergone one or more previous tumor resections. Twenty-two patients (67%) had enlarging tumors before radiosurgery. The median tumor margin dose was 16 Gy (range, 12–20 Gy). The median follow-up period after radiosurgery was 43 months (range, 16–106 mo). RESULTS Tumor size decreased for 16 patients, remained unchanged for 16 patients, and increased for 1 patient. The actuarial tumor growth control rates at 2 and 5 years after radiosurgery were 97%. No patient demonstrated any decline in visual function. Five of 18 patients (28%) with anterior pituitary function before radiosurgery developed new deficits, at a median of 24 months after radiosurgery. The actuarial risks of developing new anterior pituitary deficits were 18 and 41% at 2 and 5 years, respectively. No patient developed diabetes insipidus. CONCLUSION Stereotactic radiosurgery safely provides a high tumor control rate for patients with recurrent or residual nonfunctioning pituitary adenomas. However, despite encouraging early results, more long-term information is needed to determine whether radiosurgery is associated with lower risks of new endocrine deficits and radiation-induced neoplasms, compared with fractionated radiotherapy.


2021 ◽  
Author(s):  
Natasha Ironside ◽  
Harrison Snyder ◽  
Zhiyuan Xu ◽  
David Schlesinger ◽  
Ching-Jen Chen ◽  
...  

Abstract IntroductionDelayed hypopituitarism is the most common complication after stereotactic radiosurgery (SRS) for pituitary adenomas. The aim of this study was to investigate the relationship between the distance from the hypothalamic-pituitary axis to the treatment target and anterior pituitary function preservation after SRS. MethodsBetween 2007 and 2020, consecutive adult patients who underwent single-session SRS for pituitary adenomas with ³6 months of follow-up were included. Distance measurements between hypothalamic-pituitary axis structures and the SRS target volume were quantified on MRI. The primary outcome was anterior pituitary function preservation. Outcomes were compared using multivariable regression and area under the receiver operator characteristic curve (AUROC) analyses. ResultsThe study cohort comprised 224 patients, who were categorized by preservation (n=168) and no preservation (n=56) of anterior pituitary function after SRS. Independent predictors of anterior pituitary function preservation were a greater distance between the center of the pituitary gland and center of the SRS target (OR=1.101 [1.000–1.213], p=0.050), and a shorter clinical follow-up duration (OR=0.985 [0.977–0.993], p<0.0001). The adjusted AUROC for the distance from the center of the pituitary gland and center of the SRS target in predicting anterior pituitary function preservation was 0.595. The sensitivity, specificity, positive predictive value and negative predictive value in predicting anterior pituitary function preservation at the optimal cut-off distance of 15mm were 30.0%, 88.0%, 89.9% and 26.2%, respectively.ConclusionsGreater distance between the normal pituitary gland and the SRS target is associated with anterior pituitary function preservation and increasing this distance should be a goal of adenoma resection. Larger prospective, multi-center studies are necessary to corroborate this finding and establish the effects of distance on hypopituitarism after SRS for pituitary adenomas.


Endocrine ◽  
2020 ◽  
Vol 70 (3) ◽  
pp. 584-592
Author(s):  
Marta Araujo-Castro ◽  
Eider Pascual-Corrales ◽  
Alberto Acitores Cancela ◽  
Sara García Duque ◽  
Luis Ley Urzaiz ◽  
...  

1989 ◽  
Vol 120 (3_Suppl) ◽  
pp. S49-S50 ◽  
Author(s):  
J. SCHOPOHL ◽  
G. MEHLTRETTER ◽  
M. LOSA ◽  
G. K. STALLA ◽  
O. A. MÜLLER ◽  
...  

Contraception ◽  
1992 ◽  
Vol 46 (2) ◽  
pp. 175-179
Author(s):  
Weinyen Lu ◽  
Weiming She ◽  
Zhenyu Nan ◽  
Chungming Hsieh

2012 ◽  
Vol 97 (1) ◽  
pp. E121-E128 ◽  
Author(s):  
Marie-Hélène Quentien ◽  
Brigitte Delemer ◽  
Dimitris T. Papadimitriou ◽  
Pierre-François Souchon ◽  
Roland Jaussaud ◽  
...  

1977 ◽  
Vol 17pt2 (3) ◽  
pp. 219-225
Author(s):  
SHIGEJIRO MATSUMURA ◽  
SHINTARO MORI ◽  
HISANORI YOSHIMOTO ◽  
MASAHIRO OHTA ◽  
HIROMICHI HIBINO ◽  
...  

Author(s):  
P. Franchimont ◽  
J. J. Legros ◽  
B. Deconinck ◽  
P. Demeyts ◽  
M. Goulart ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document